Atlas Trials

Comparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prostate Cancer

Clinical trial NCT01578655 · COMPLETED

Trial details

NCT number
NCT01578655
Sponsor
Achieve Life Sciences
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2012-08-01
Primary completion
2016-07-01
Enrollment
630

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.